Nordstrom Robert J
Cancer Imaging Program, National Cancer Institute, Division of Cancer Treatment and Diagnosis, Bethesda, Maryland.
Tomography. 2016 Dec;2(4):239-241. doi: 10.18383/j.tom.2016.00190.
Precision medicine is a healthcare model that seeks to incorporate a wealth of patient information to identify and classify disease progression and to provide tailored therapeutic solutions for individual patients. Interventions are based on knowledge of molecular and mechanistic causes, pathogenesis and pathology of disease. Individual characteristics of the patients are then used to select appropriate healthcare options. Imaging is playing an increasingly important role in identifying relevant characteristics that help to stratify patients for different interventions. However, lack of standards, limitations in image-processing interoperability, and errors in data collection can limit the applicability of imaging in clinical decision support. Quantitative imaging is the attempt to extract reliable, numerical information from images to eliminate qualitative judgments and errors for providing accurate measures of tumor response to therapy or for predicting future response. This issue of reports quantitative imaging developments made by several members of the National Cancer Institute Quantitative Imaging Network, a program dedicated to the promotion of quantitative imaging methods for clinical decision support.
精准医学是一种医疗模式,旨在整合大量患者信息,以识别和分类疾病进展情况,并为个体患者提供量身定制的治疗方案。干预措施基于对疾病分子和机制病因、发病机制及病理的了解。然后利用患者的个体特征来选择合适的医疗选项。成像在识别有助于对患者进行分层以采取不同干预措施的相关特征方面正发挥着越来越重要的作用。然而,缺乏标准、图像处理互操作性的局限性以及数据收集方面的错误会限制成像在临床决策支持中的适用性。定量成像旨在从图像中提取可靠的数值信息,以消除定性判断和误差,从而准确衡量肿瘤对治疗的反应或预测未来反应。本期 报告了美国国立癌症研究所定量成像网络的几位成员在定量成像方面取得的进展,该项目致力于推广用于临床决策支持的定量成像方法。